This inventor holds 1 USPTO granted patent. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Roberta Ellen Glynn: Innovator in Aryl Alkenamides Derivatives
Introduction
Roberta Ellen Glynn is a notable inventor based in Waltham, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can impact human health.
Latest Patents
Roberta holds a patent for "Aryl alkenamides derivatives as MCP-1 antagonists." This innovative work focuses on creating derivatives that can potentially serve as therapeutic agents in various medical applications.
Career Highlights
Roberta is associated with Millennium Pharmaceuticals Limited, where she has been instrumental in advancing research and development efforts. Her work has contributed to the company's reputation as a leader in the pharmaceutical industry.
Collaborations
Roberta has collaborated with esteemed colleagues, including Richard John Booth and Kenneth Gordon Carson. These partnerships have fostered a productive environment for innovation and discovery.
Conclusion
Roberta Ellen Glynn's contributions to the field of pharmaceuticals through her patent and collaborations highlight her role as a significant inventor. Her work continues to influence advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile